CURIS, INC. Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31)
CURIS, INC. (CRIS) had Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) of $15.74 thousand as of 2012-12-31, per its 10-K filed 2013-03-13.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGainLoss · last filed 2013-03-13
- 2012-12-31: Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) $15.74K.
- 2012-09-30: Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) -$8.73K.
- 2012-06-30: Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) $7.18K.
- 2011-12-31: Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) $1.43K.
| Period end | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) |
|---|---|
| 2012-12-31 | $15.74K 10-K · filed 2013-03-13 |
| 2012-09-30 | -$8.73K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $7.18K 10-Q · filed 2012-08-09 |
| 2011-12-31 | $1.43K 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |